Brief: Madenco Biosciences Announces Strategic Decision To Drop Consumer Health Products

Quest PharmaTech

20/07/2018 21:47

July 20 (Reuters) - Quest Pharmatech Inc  QPT.V :
    * MADENCO BIOSCIENCES ANNOUNCES STRATEGIC DECISION TO DROP
CONSUMER HEALTH PRODUCTS AND FOCUS ON PHARMACEUTICAL PRODUCT
DEVELOPMENT
    * MADENCO BIOSCIENCES SAYS WILL NO LONGER PROMOTE BELLUS
SKIN LINE
OF SKIN CARE PRODUCTS
    * MADENCO BIOSCIENCES SAYS DETERMINED THAT CONSUMER HEALTH
PRODUCTS ARE NOT PROVIDING RETURNS ON CAPITAL THAT CO EXPECTS
    * MADENCO BIOSCIENCES SAYS ALSO NEGOTIATED A RETURN OF ITS
PRINCIPAL INVESTMENT IN NATURAL RF LIFE SCIENCES
    * MADENCO BIOSCIENCES - CONTINUES TO HAVE ABOUT 20% EQUITY
INTEREST IN SOUTH KOREA BASED BIOCELTRAN

Source text for Eikon:  ID:nCNW3Dss7a 
Further company coverage:  QPT.V 

 ((Reuters.Briefs@thomsonreuters.com;))